| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |